Nova Eye Medical (EYE) Discussion, page-1310

Anyone in DXB? Up more than 150% after securing a decent (but not anything super remarkable) deal for its product. I reckon 2RT will score a substantially better deal (especially in relation to the upfront payment) given the significantly larger TAM which 2RT targets, as well as a number of other factors. However, it does indicate what we can expect to see as a minimum when a partnership for 2RT is announced. Also worth noting that EYE is a bit less than double the market capitalisation of DXB, which is not much at all considering the fact that EYE is generating strong revenue of $20m at a high growth rate from iTrack Advance. Clearly 2RT is not being priced into the share price yet, so any partnership arrangement should see a significant rerate (likely multiples higher than the current price)